A spotlight on women’s health

For centuries, women’s health has been neglected across science, medicine and technology. A new report from the World Economic Forum suggests tackling this could unlock a $1 trillion economic boost with the potential to change the lives of 3.9 billion women.

Sano Chemicals, located in Bryan, Texas, specializes in the development of first-in-class drugs, with its current lead being the unique fungicide occidiofungin.

Coagulant Therapeutics is developing a novel pipeline of therapeutics to treat acute bleeds led by CT-001, a next-generation factor VIIa (FVIIa) molecule.

BIOMILQ is bridging the gap between infant formula and breast milk by producing high-value ingredients from human mammary epithelial cells.

How NextGen Jane’s menstrual data platform is addressing some of the most prevalent unmet healthcare needs.